Song Y. Lavalais

FDA investigator

Appears on 5 documents from 2021 to 2023, most often at sites in Georgia. Most often cites control of microbiological contamination (21 CFR 211.113).

5
Documents on file
6.4
Observations per 483
2021
First seen
2023
Most recent

What they cite most

From 32 observations

Activity by year

2021: 2, 2022: 2, 2023: 1

Where

Georgia 2 · North Carolina 2 · South Carolina 1

Is Song Y. Lavalais coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Nephron Sterile Compounding Center LLCFeb 10, 2023 · West Columbia, South Carolina
483 Biogen U.S. CorporationAug 26, 2022 · Morrisville, North Carolina
483 Family Pharmacy of Statesville, IncMar 11, 2022 · Statesville, North Carolina
483 Acella Pharmaceuticals, LLCSep 17, 2021 · Alpharetta, Georgia
483 HomeChoice Partners dba BioScrip Infusion ServicesAug 9, 2021 · Augusta, Georgia

About this profile

What does Song Y. Lavalais inspect?

Song Y. Lavalais appears on 5 documents on file covering 5 sites, most often in Georgia.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Song Y. Lavalais is dated Feb 10, 2023.